Biofrontera AG

FSX:B8F.DE

6.804 (EUR) • At close May 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 7.457.01511.9855.7993.836.8328.516.56610.3145.3797.6155.4799.5174.7139.6436.47312.2065.1557.0966.8086.5555.5834.2934.6764.6912.3282.392.6163.2491.1730.6921.0171.5031.0670.5381.031.1040.7750.5670.651.2470.4830.7510.634
Cost of Revenue 1.4361.2442.3131.2510.8981.0891.6581.1111.2010.6991.1110.9010.9691.0760.6920.7990.6821.711.520.9631.671.1290.9820.6710.8150.2640.2720.3630.6230.2650.4030.3610.3750.3260.2240.310.2420.5270.1680.180.3090.3920.3110.592
Gross Profit 6.0145.7719.6724.5482.9325.7436.8525.4559.1134.686.5044.5788.5483.6378.9515.67411.5243.4455.5765.8454.8864.4543.314.0063.8762.0632.1182.2532.6250.9080.2890.6561.1280.7410.3140.720.8620.2490.3990.470.9380.0910.440.042
Gross Profit Ratio 0.8070.8230.8070.7840.7660.8410.8050.8310.8840.870.8540.8360.8980.7720.9280.8770.9440.6680.7860.8590.7450.7980.7710.8570.8260.8860.8860.8610.8080.7740.4180.6450.750.6940.5840.6990.7810.3210.7030.7230.7520.1890.5860.066
Reseach & Development Expenses 1.6052.3152.0831.8422.1841.8091.5331.6012.4931.5951.6041.3171.3861.0141.0781.3111.4210.8941.2341.0881.2081.0311.250.9380.9921.0481.0581.1271.2821.5060.8471.0050.8390.8673.2581.241.3881.0830.9231.141.2360.7870.5820.581
General & Administrative Expenses 1.6521.011.6921.7512.2361.1071.5271.03623.2242.0043.0152.5382.2682.472.182.2324.1674.345.7941.9745.683.2042.6631.416-0.5291.930.8810.8140.7720.7080.5840.7890.6990.7130.7140.6330.6820.7022.0611.6873.640.6011.80.867
Selling & Marketing Expenses 2.1051.5041.8471.8181.6331.3671.6921.6656.166.0725.3784.8134.1424.1893.4538.6988.2216.448.6415.5545.0864.3474.014.3014.3364.3114.693.5863.8262.1051.6371.1961.2410.8911.0930.9451.0580.78100-2.1760.73200
SG&A 3.7572.5143.5393.5693.8692.4743.2192.70129.3848.0768.3937.3516.416.6595.63310.9312.38810.7814.4357.52810.7667.5526.6735.7163.8076.2415.5714.44.5982.8142.221.9841.941.6041.8071.5781.7411.4832.0611.6871.4631.3331.80.867
Other Expenses 0.1310.050.0680.103-0.192-0.013-0.202-0.05959.5660.2440.0730.119-0.79-1.437-1.2031.01215.170.1035.3770.5360.42-0.090.9-0.262-0.168-0.279-0.563-0.0640.1420.030.0542.1780.0380.0630.0770.009-0.2240.0380.0640.0270.0210.0150.1550.113
Operating Expenses 5.3624.8296.0085.4116.0534.2834.7524.30231.8779.6719.9978.6687.7967.6736.71112.24113.80911.67415.6698.61611.9748.5837.9236.6554.7997.2896.6295.5275.884.323.0682.9892.782.4715.0652.8183.1292.5662.9842.8272.6992.1192.3821.448
Operating Income 0.6520.9424.05-0.863-3.1211.462.11.152-22.767-4.991-3.494-4.0890.753-4.0362.24-6.567-2.284-8.229-10.094-2.77-7.088-4.129-4.613-2.649-0.923-5.226-4.511-3.274-3.255-3.412-2.778-2.333-1.652-1.73-4.75-2.098-2.267-2.317-2.585-2.358-1.761-2.028-1.942-1.406
Operating Income Ratio 0.0880.1340.338-0.149-0.8150.2140.2470.175-2.207-0.928-0.459-0.7460.079-0.8560.232-1.015-0.187-1.596-1.422-0.407-1.081-0.74-1.075-0.566-0.197-2.245-1.887-1.251-1.002-2.909-4.016-2.295-1.099-1.622-8.828-2.037-2.054-2.989-4.559-3.63-1.413-4.203-2.585-2.218
Total Other Income Expenses Net 0.128-3.387-3.218-2.5330.584-6.072-10.061-29.25273.0790.2440.0730.119-0.79-1.437-1.2031.0120.357-2.40722.70.5360.42-0.090.9-0.262-0.168-0.279-0.563-0.0640.1420.030.0542.1780.0380.0630.0770.009-0.2240.0380.0640.0270.0210.0150.1550.113
Income Before Tax 0.78-2.4450.832-3.396-2.537-4.612-7.961-28.150.312-5.795-3.959-4.876-1.062-6.4010.265-5.498-2.253-11.5511.664-2.637-7.017-4.568-4.273-3.412-1.488-5.878-5.224-3.513-3.415-3.692-3.025-0.448-1.918-1.963-4.96-2.362-2.766-2.543-2.775-2.638-2.045-2.324-2.138-1.559
Income Before Tax Ratio 0.105-0.3490.069-0.586-0.662-0.675-0.935-4.284.878-1.077-0.52-0.89-0.112-1.3580.027-0.849-0.185-2.2411.644-0.387-1.07-0.818-0.995-0.73-0.317-2.525-2.186-1.343-1.051-3.148-4.372-0.44-1.276-1.84-9.219-2.294-2.506-3.28-4.894-4.061-1.64-4.814-2.847-2.459
Income Tax Expense -3.420.6960.8870.079-0.2180.4910.68429.1982.3540.0060.0370.001-0.0660.0540.3370.0012.5562.5030.026-0.541-10.3950.004-0.2520.020.5640.6520.7130.2380.16100.2460.2930.266-000-0.0090.0030.0030.003-0.0160.2950.1970.153
Net Income 5.917-3.1410.33-3.475-2.319-5.103-8.645-57.29850.2-5.732-3.995-4.877-2.12-5.4980.093-5.499-4.379-11.82211.194-2.6373.85-4.633-4.924-3.172-1.488-5.878-5.224-3.513-3.415-3.692-3.025-0.448-1.918-1.963-4.96-2.362-2.756-2.546-2.778-2.641-2.045-2.324-2.138-1.559
Net Income Ratio 0.794-0.4480.028-0.599-0.605-0.747-1.016-8.7264.867-1.066-0.525-0.89-0.223-1.1670.01-0.85-0.359-2.2931.578-0.3870.587-0.83-1.147-0.678-0.317-2.525-2.186-1.343-1.051-3.148-4.372-0.44-1.276-1.84-9.219-2.294-2.497-3.284-4.899-4.066-1.64-4.814-2.847-2.459
EPS 0.093-0.050.005-0.055-0.036-0.09-0.15-1.020-0.097-0.074-0.086-0.047-0.11-0.002-0.13-0.098-0.250.25-0.0560.086-0.097-0.11-0.075-0.033-0.14-0.12-0.087-0.076-0.11-0.067-0.014-0.043-0.064-0.11-0.082-0.062-0.093-0.062-0.092-0.046-0.11-0.048-0.068
EPS Diluted 0.093-0.050.005-0.055-0.036-0.086-0.15-0.980-0.097-0.074-0.086-0.047-0.11-0.002-0.13-0.098-0.250.25-0.0560.086-0.097-0.11-0.075-0.033-0.14-0.12-0.087-0.076-0.11-0.067-0.014-0.043-0.064-0.11-0.082-0.062-0.093-0.062-0.092-0.046-0.11-0.048-0.068
EBITDA 0.941-2.4410.834-3.391-2.506-4.591-7.905-28.04651.53-4.746-3.417-3.966-0.084-5.4731.005-4.992-2.186-7.9512.81-2.229-6.498-4.012-3.71-2.909-0.849-5.273-4.849-3.114-2.888-3.18-2.5160.043-1.407-1.467-4.467-1.882-2.149-2.063-2.371-2.162-1.857-1.828-1.76-1.228
EBITDA Ratio 0.126-0.3480.07-0.585-0.654-0.672-0.929-4.2714.996-0.882-0.449-0.724-0.009-1.1610.104-0.771-0.179-1.5421.805-0.327-0.991-0.719-0.864-0.622-0.181-2.265-2.029-1.19-0.889-2.711-3.6370.042-0.936-1.375-8.301-1.827-1.947-2.66-4.182-3.329-1.489-3.788-2.343-1.936